The scientific sessions will cover a variety of pressing and clinically highly relevant topics like „Treatment approaches in lymphoma and in solid cancers“, „Cancer immunotherapy“ and „Assessing and predicting treatment responses“ as well as technically oriented, innovative fields like „New technologies“ und „Biomedical engineering“.

The conference addresses clinicians, scientists and clinical scientists alike which will promote the scientific exchange within these overlapping fields.